About: polycystic ovary

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: polycystic ovary Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

illness

Attributes	Values
rdf:type	Item
description	Krankheit (de) maladie (fr) illness (en) sykdom (nb) хвороба (uk) trastorno hormonal (es)
rdfs:label	PCO (de) PCO (fi) polycystic ovary (en) ovaire polykistique (fr) ovari poliquístic (ca) ovario poliquístico (es) policistični jajčnik (sl) polycystisk ovarie (nb)
skos:prefLabel	PCO (de) PCO (fi) polycystic ovary (en) ovaire polykistique (fr) ovari poliquístic (ca) ovario poliquístico (es) policistični jajčnik (sl) polycystisk ovarie (nb)
name	PCO (de) PCO (fi) polycystic ovary (en) ovaire polykistique (fr) ovari poliquístic (ca) ovario poliquístico (es) policistični jajčnik (sl) polycystisk ovarie (nb)
instance of	wds:Q5547896-69c10537-4c97-a3a6-eef7-debb7a440383
instance of	disease
subclass of	wds:Q5547896-efd647e5-41fc-4b14-782d-b32d8decc899 wds:Q5547896-faf6795c-4761-da0b-48b6-53b5b371b302
subclass of	ovarian cyst ovarian dysfunction
Google Knowledge Graph ID	wds:Q5547896-D95E6A61-1320-47F1-8C53-1142CF0AF84A
Google Knowledge Graph ID	http://g.co/kg/g/122jxb90
Google Knowledge Graph ID	/g/122jxb90
skos:altLabel	PCO (en) PCOS (nb) PCO (fr) PCO (nb) polycystic ovaries (en)
UMLS CUI	wds:Q5547896-9fb8f104-4d9a-05d3-e57b-479c6bcbb6fd
ICD-11 ID (MMS)	wds:Q5547896-2766075d-5c0a-4ba5-afb1-f151dd7100df
ICD-11 (foundation)	wds:Q5547896-40e8e2bc-473c-84af-5851-fc1c1888f059
UMLS CUI	CL949301
ICD-11 ID (MMS)	5A80.2
ICD-11 (foundation)	751558883
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q5547896 https://fi.wikipedia.org/wiki/PCO
is main subject of	wds:Q124556074-174512b8-48cc-c629-68fd-40d54db7f0b4
is symptoms and signs of	polycystic ovary syndrome
is symptoms and signs of	wds:Q500816-44937250-4d8b-69e9-c400-230104bca01a
is main subject of	Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Impact of obesity on the risk for polycystic ovary syndrome Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline Follicular dynamics in the polycystic ovary syndrome Polycystic ovary syndrome and its developmental origins. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth A twenty-first century research agenda for polycystic ovary syndrome Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment. Polycystic ovary syndrome Regulation of gonadotropin secretion: implications for polycystic ovary syndrome Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS). Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. The plasminogen activator system in women with polycystic ovary syndrome Bone mineral density in women with polycystic ovary syndrome Glucose intolerance states in women with the polycystic ovary syndrome Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome Bone mineral density and body composition in lean women with polycystic ovary syndrome Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study [The controversies in the diagnosis of polycystic ovary syndrome] In vitro maturation and fertilization of oocytes from unstimulated ovaries in infertile women with polycystic ovary syndrome Successful monozygotic twin delivery following in vitro maturation of oocytes retrieved from a woman with polycystic ovary syndrome: case report. Advances in polycystic ovary syndrome treatment: metformin and ovarian diathermy Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial Electrical vs manual acupuncture stimulation in a rat model of polycystic ovary syndrome: different effects on muscle and fat tissue insulin signaling The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome How does acupuncture affect insulin sensitivity in women with polycystic ovary syndrome and insulin resistance? Study protocol of a prospective pilot study Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software